Skip to Content

Dritho Creme

Generic Name: anthralin
Dosage Form: cream

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

COMPOSITION: CREAM CONTAINING ANTHRALIN U.S.P. 1.0%

A BASE OF WHITE PETROLATUM, SODIUM LAURYL SULFATE, CETOSTEARYL ALCOHOL, ASCORBIC ACID, SALICYLIC ACID, METHYLPARABEN AND PURIFIED WATER.

INDICATION

AN AID IN THE TOPICAL TREATMENT OF QUIESCENT OR CHRONIC PSORIASIS.

WARNING

FOR EXTERNAL USE ONLY.

AN AID IN THE TOPICAL TREATMENT OF PSORIASIS.

KEEP OUT OF THE REACH OF CHILDREN.

DRITHO-CREME   HP
anthralin cream
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:11086-037
Route of Administration TOPICAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ANTHRALIN (ANTHRALIN) ANTHRALIN 1 g  in 100 g
Inactive Ingredients
Ingredient Name Strength
PETROLATUM  
SODIUM LAURYL SULFATE  
CETOSTEARYL ALCOHOL  
ASCORBIC ACID  
SALICYLIC ACID  
METHYLPARABEN  
WATER  
Packaging
# Item Code Package Description
1 NDC:11086-037-01 50 g in 1 TUBE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 01/01/2013
Labeler - Summers Laboratories Inc (002382612)
Establishment
Name Address ID/FEI Operations
Summers Laboratories Inc 002382612 manufacture(11086-037)
Revised: 10/2014
 
Summers Laboratories Inc



More about Drithocreme (anthralin topical)

Consumer resources

Professional resources

Related treatment guides

Hide